Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Pfizer designs new sodium/glucose cotransporter 2 inhibitors

May 25, 2011

New free fatty acid FFA1 receptor agonists disclosed

May 25, 2011

Gactiv approved in Japan for type 2 diabetes in combination with alpha-glucosidase inhibitors

May 24, 2011

Sosei launches NorLevo emergency contraceptive pill in Japan

May 24, 2011

First patients enrolled in phase I trial of Glycotope's FSH-GEX

May 24, 2011

FDA advisory committee recommends retention of indication for Abbott's Trilipix

May 23, 2011

FDA places new restrictions on use of rosiglitazone-containing medicines

May 20, 2011

Zydus-Cadila presents new peptidomimetic GLP-1 agonists/glucagon receptor antagonists

May 20, 2011

Synergy Pharmaceuticals advances GC-C agonist program for lowering cholesterol

May 19, 2011

NORD grants 2011 Corporate Award to Recordati for Carbaglu

May 19, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...